Business Context and Reporting Period
This Form 8-K is a current report filed by Miragen Therapeutics, Inc. (not Viridian Therapeutics, Inc.) on June 8, 2017. The registrant is a Delaware corporation headquartered in Boulder, Colorado, and is classified as an emerging growth company. The filing primarily addresses "Other Events" related to upcoming clinical data presentations and conference appearances.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate events rather than financial performance data.
Material Changes
No material financial changes versus prior periods are disclosed in this document. The report details the following operational events:
- Announcement of the presentation of MRG-106 Phase 1 clinical trial data at the 14th International Conference on Malignant Lymphoma (June 14-17, 2017, in Lugano, Switzerland).
- Disclosure of additional potential clinical milestones for the Company in 2017 and 2018.
- Scheduled presentation at the Jefferies Healthcare Conference regarding product candidate development.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of upcoming clinical milestones for 2017 and 2018, though specific details of these milestones are contained in the attached press release (Exhibit 99.1) and presentation (Exhibit 99.2) rather than the body of this 8-K. No specific financial guidance, risk factors, or contingencies are detailed in the text of this filing.
Investor Verification Checklist
- Verify the correct registrant name: The filing is for Miragen Therapeutics, Inc., not Viridian Therapeutics, Inc.
- Review Exhibit 99.1 (Press Release) for specific details on the MRG-106 Phase 1 data and the 2017-2018 clinical milestones.
- Review Exhibit 99.2 (Presentation) for further insights into product candidate development discussed at the Jefferies Healthcare Conference.
- Confirm the dates and location of the International Conference on Malignant Lymphoma (June 14-17, 2017, Lugano, Switzerland).